Subscribe

Rapid Micro Biosystems, Inc. (RPID)

USD2.13 +0.06 (+2.90%)
US NASDAQ Healthcare Medical - Devices
Address 1001 Pawtucket Boulevard West 1854
Lowell, MA, US
CEO Robert G. Spignesi Jr.
IPO 2021-07-15
CIK 1380106 ISIN US75340L1044

Explore sections of this company profile

Description

Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD2.13 +0.06 (+2.90%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
168.8K
Beta
1.47
Float Shares
21.59M
Free Float %
47.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +2.79% +21.70% -32.28% -37.68% -11.03% -11.64% +185.05% -87.94% -87.94% -87.94%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (4 ratings, all time) Buy
Price Targets & DCF
Current price
2.13
Low 8.00 +275.6%
Consensus 8.00 +275.6%
Median 8.00 +275.6%
High 8.00 +275.6%
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 4 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year
All Time 1
8.00
+275.6%
Quality scores
Altman Z-Score
-9.03
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Devices: +11.2%
    +19.7% Q1'26: +11.1% (vs Q1'25)
  • EPS growth Medical - Devices: +28.5%
    +2.8% Q1'26: -19.2% (vs Q1'25)
  • FCF margin FCF growth · Medical - Devices: +30.9%
    -119.3% Q1'26: -30.7% (vs Q1'25)
  • EBIT margin Medical - Devices: +6.2%
    -141.1% Q1'26: +0.0% (vs Q1'25)
  • ROIC Medical - Devices: +3.3%
    -252.3% Q1'26: +0.0% (vs Q1'25)
  • Share dilution Medical - Devices: 0.0%
    +2.5% Q1'26: +3.3% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    -0.54× Q1'26: -0.43× (vs Q1'25)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.53) × ERP
WACC = 83% × Ke + 17% × Kd (4.6%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 2.13
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
3 Rev. Ana.
2 EPS Ana.
Dec 2027
3 Rev. Ana.
2 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Dec 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
23.23M
est: 23.66M (-1.8%)
17.13M
est: 17.33M (-1.2%)
22.52M
est: 23.10M (-2.5%)
28.05M
est: 27.67M (+1.4%)
33.59M
est: 33.65M (-0.2%)
39.23M
38.50M – 39.92M
+16.6% YoY
46.45M
45.59M – 47.27M
+18.4% YoY
62.30M
61.14M – 63.40M
+34.1% YoY
74.70M
73.31M – 76.02M
+19.9% YoY
EBITDA
-45.70M
est: -23.66M (-93.1%)
-60.38M
est: -17.33M (-248.4%)
-53.46M
est: -23.10M (-131.5%)
-46.56M
est: -27.67M (-68.3%)
-44.14M
est: -33.65M (-31.2%)
-39.23M
-39.92M – -38.50M
-16.6% YoY
-46.45M
-47.27M – -45.59M
-18.4% YoY
-62.30M
-63.40M – -61.14M
-34.1% YoY
-74.70M
-76.02M – -73.31M
-19.9% YoY
EBIT
-47.23M
est: -23.66M (-99.6%)
-63.22M
est: -17.33M (-264.7%)
-56.56M
est: -23.10M (-144.9%)
-49.92M
est: -27.67M (-80.4%)
-47.39M
est: -33.65M (-40.8%)
-39.23M
-39.92M – -38.50M
-16.6% YoY
-46.45M
-47.27M – -45.59M
-18.4% YoY
-62.30M
-63.40M – -61.14M
-34.1% YoY
-74.70M
-76.02M – -73.31M
-19.9% YoY
Net Income
-73.52M
est: -103.71M (+29.1%)
-60.81M
est: -61.59M (+1.3%)
-52.47M
est: -53.73M (+2.4%)
-46.89M
est: -48.37M (+3.1%)
-47.12M
est: -44.95M (-4.8%)
-41.23M
-42.20M – -40.26M
+8.3% YoY
-37.00M
-37.63M – -35.90M
+10.3% YoY
-26.50M
-26.51M – -25.29M
+28.4% YoY
-21.00M
-21.48M – -20.49M
+20.8% YoY
SGA
29.71M
est: 36.27M (-18.1%)
41.81M
est: 26.57M (+57.4%)
38.26M
est: 35.62M (+7.4%)
35.21M
est: 42.67M (-17.5%)
34.84M
est: 51.89M (-32.9%)
60.49M
59.37M – 61.56M
+16.6% YoY
71.63M
70.30M – 72.90M
+18.4% YoY
96.08M
94.29M – 97.77M
+34.1% YoY
115.20M
113.06M – 117.23M
+19.9% YoY
EPS
-1.88
est: -2.38 (+21.0%)
-1.43
est: -1.41 (-1.2%)
-1.22
est: -1.20 (-1.4%)
-1.08
est: -1.08 (+0.3%)
-1.05
est: -1.01 (-4.3%)
-0.92
-0.94 – -0.90
+8.3% YoY
-0.82
-0.84 – -0.80
+10.8% YoY
-0.58
-0.59 – -0.57
+29.6% YoY
-0.47
-0.48 – -0.46
+19.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-01 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-16 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-27.67M
OE per share TTM
-0.62
Owner's Yield
-24.04%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
60.7%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
42
Total invested
42.50M
Insider transactions (90d)
0
Beneficial owners (>5%)
27
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Bain Capital Life Sciences Fund, L.P. 7.65M 22.20% 7.65M 7.65M PN Delaware 2022-02-14
2 Darren Richman 5.00M 13.70% 5.00M 5.00M HC, IN USA 2022-05-19
3 David Chene 5.00M 13.70% 5.00M 5.00M HC, IN USA 2022-05-19
4 KLM GP LLC 5.00M 13.70% 5.00M 5.00M HC, OO USA 2022-05-19
5 Kennedy Lewis Investment Holdings II LLC 5.00M 13.70% 5.00M 5.00M OO USA 2022-05-19
6 Kennedy Lewis Investment Management LLC 5.00M 13.70% 5.00M 5.00M HC, OO USA 2022-05-19
7 Kennedy Lewis Management LP 5.00M 13.70% 5.00M 5.00M IA, PN USA 2022-05-19
8 Juliet Tammenoms Bakker 4.19M 12.20% 4.19M 4.19M IN Delaware 2022-02-15
9 Patrick G. Enright 4.19M 12.20% 4.19M 4.19M IN Delaware 2022-02-15
10 David Hirsch 4.05M 11.80% 5.6K 4.04M 5.6K 4.04M IN Delaware 2022-02-15
11 Longitude Capital Partners II, LLC 4.04M 11.70% 4.04M 4.04M OO Delaware 2022-02-15
12 Longitude Venture Partners II, L.P. 4.04M 11.70% 4.04M 4.04M PN Delaware 2022-02-15
13 Kennedy Lewis Capital Partners Master Fund III LP 2.80M 7.70% 2.80M 2.80M PN USA 2022-05-19
14 Kennedy Lewis GP III LLC 2.80M 7.70% 2.80M 2.80M OO USA 2022-05-19
15 D1 Capital Partners L.P. 2.64M 7.70% 2.64M IA, PN Delaware 2022-02-14
16 Daniel Sundheim 2.64M 7.70% 2.64M HC, IN Delaware 2022-02-14
17 Kennedy Lewis Capital Partners Master Fund II LP 2.20M 6.00% 2.20M 2.20M PN USA 2022-05-19
18 Kennedy Lewis GP II LLC 2.20M 6.00% 2.20M 2.20M OO USA 2022-05-19
19 52-0556948 2.20M 6.30% 488.3K 2.20M IA Maryland 2022-02-14
20 85-4328500 2.19M 6.00% 694.2K 2.19M IA Maryland 2023-02-14
21 Colony Harvest Ltd. 2.08M 6.10% 2.08M CO Cayman Islands 2022-02-11
22 Fares Zahir 2.08M 6.10% 2.08M IN Malaysia 2022-02-11
23 (1) 2.04M 6.00% 2.04M 2.04M PN Gursney 2021-08-30
24 JPMORGAN CHASE & CO.13-2624428 1.78M 5.10% 1.57M 1.78M HC Delaware 2022-01-26
25 BCIP Life Sciences Associates, LP 783.2K 2.30% 783.2K 783.2K PN Delaware 2022-02-14
26 Longitude Prime Fund, L.P. 150.0K 0.40% 150.0K 150.0K PN Delaware 2022-02-15
27 Longitude Prime Partners, LLC 150.0K 0.40% 150.0K 150.0K OO Delaware 2022-02-15

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2025 Q4
Investors holding
42
+13 vs prev Q
New positions
15
Closed positions
2
Increased
27
Reduced
7
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 NANO CAP NEW MILLENNIUM GROWTH FUND L P 25.0K +25.0K (+100.0%) 72.50M +72.5M (+100.0%) 0.06% +0.056 pp 0.06% +0.062 pp USD2.90 +0.0% 1 qtrs NEW
2 BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 8.43M +— (+0.0%) 24.46M -3.7M (-13.2%) 18.94% +0.048 pp 1.87% +0.004 pp USD18.47 -84.3% 18 qtrs
3 ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD 1.85M +— (+0.0%) 5.36M -813.3K (-13.2%) 4.15% +0.011 pp 35.62% +2.562 pp USD4.97 -41.6% 16 qtrs
4 VANGUARD GROUP INC 978.8K +13.8K (+1.4%) 2.84M -384.7K (-11.9%) 2.20% +0.036 pp 0.00% +0.000 pp USD8.89 -67.4% 18 qtrs
5 ADVENT INTERNATIONAL CORP/MA 577.8K +— (+0.0%) 1.68M -254.2K (-13.2%) 1.30% +0.003 pp 0.03% -0.004 pp USD18.47 -84.3% 18 qtrs
6 PARKMAN HEALTHCARE PARTNERS LLC 354.5K -559.0K (-61.2%) 1.03M -2.0M (-66.3%) 0.80% -1.250 pp 0.10% -0.220 pp USD2.80 +3.6% 4 qtrs
7 SCHONFELD STRATEGIC ADVISORS LLC 352.4K -294.1K (-45.5%) 1.02M -1.1M (-52.7%) 0.79% -0.657 pp 0.00% -0.008 pp USD2.65 +9.4% 4 qtrs
8 GEODE CAPITAL MANAGEMENT, LLC 217.6K +12.9K (+6.3%) 631.1K -52.7K (-7.7%) 0.49% +0.030 pp 0.00% +0.000 pp USD5.83 -50.3% 18 qtrs
9 SUSQUEHANNA INTERNATIONAL GROUP, LLP 172.2K +113.8K (+195.0%) 499.5K +304.5K (+156.1%) 0.39% +0.256 pp 0.00% +0.000 pp USD2.84 +2.1% 4 qtrs
10 EVERNEST FINANCIAL ADVISORS, LLC 125.0K -75.2K (-37.6%) 468.8K -200.0K (-29.9%) 0.28% -0.168 pp 0.10% -0.089 pp USD3.19 -9.1% 4 qtrs
11 BLACKROCK, INC. 156.7K -327.2K (-67.6%) 454.3K -1.2M (-71.9%) 0.35% -0.732 pp 0.00% +0.000 pp USD1.11 +161.3% 6 qtrs
12 CITADEL ADVISORS LLC 126.5K +126.5K (+100.0%) 367.0K +367.0K (+100.0%) 0.28% +0.284 pp 0.00% +0.000 pp USD2.90 +0.0% 5 qtrs
13 683 CAPITAL MANAGEMENT, LLC 120.8K +120.8K (+100.0%) 350.2K +350.2K (+100.0%) 0.27% +0.271 pp 0.02% +0.015 pp USD2.90 +0.0% 1 qtrs NEW
14 MILLENNIUM MANAGEMENT LLC 116.5K +116.5K (+100.0%) 337.9K +337.9K (+100.0%) 0.26% +0.262 pp 0.00% +0.000 pp USD2.90 +0.0% 1 qtrs NEW
15 RENAISSANCE TECHNOLOGIES LLC 115.6K +5.4K (+4.9%) 335.3K -32.7K (-8.9%) 0.26% +0.013 pp 0.00% +0.000 pp USD0.99 +192.9% 12 qtrs
16 JANE STREET GROUP, LLC 105.3K +67.2K (+176.1%) 305.4K +178.0K (+139.7%) 0.24% +0.151 pp 0.00% +0.000 pp USD3.06 -5.2% 2 qtrs
17 SEI INVESTMENTS CO 93.6K +93.6K (+100.0%) 271.5K +271.5K (+100.0%) 0.21% +0.210 pp 0.00% +0.000 pp USD2.90 +0.0% 1 qtrs NEW
18 STATE STREET CORP 91.5K +— (+0.0%) 265.3K -40.2K (-13.2%) 0.21% +0.001 pp 0.00% +0.000 pp USD5.48 -47.1% 18 qtrs
19 EAM INVESTORS, LLC 77.2K +77.2K (+100.0%) 223.8K +223.8K (+100.0%) 0.17% +0.173 pp 0.02% +0.025 pp USD2.90 +0.0% 4 qtrs
20 MARSHALL WACE, LLP 62.9K +62.9K (+100.0%) 182.4K +182.4K (+100.0%) 0.14% +0.141 pp 0.00% +0.000 pp USD2.90 +0.0% 1 qtrs NEW
21 ESSEX INVESTMENT MANAGEMENT CO LLC 62.3K +— (+0.0%) 180.7K -27.4K (-13.2%) 0.14% +0.000 pp 0.03% -0.004 pp USD2.64 +9.8% 4 qtrs
22 DIMENSIONAL FUND ADVISORS LP 56.2K +540.0 (+1.0%) 162.5K -23.2K (-12.5%) 0.13% +0.002 pp 0.00% +0.000 pp USD3.11 -6.8% 4 qtrs
23 GOLDMAN SACHS GROUP INC 55.3K +55.3K (+100.0%) 160.4K +160.4K (+100.0%) 0.12% +0.124 pp 0.00% +0.000 pp USD2.90 +0.0% 1 qtrs NEW
24 NORTHERN TRUST CORP 40.5K -7.2K (-15.2%) 117.4K -42.0K (-26.3%) 0.09% -0.016 pp 0.00% +0.000 pp USD6.13 -52.7% 18 qtrs
25 QUBE RESEARCH & TECHNOLOGIES LTD 33.1K +33.1K (+100.0%) 96.0K +96.0K (+100.0%) 0.07% +0.074 pp 0.00% +0.000 pp USD2.90 +0.0% 1 qtrs NEW
26 MORGAN STANLEY 31.4K +10.8K (+52.7%) 91.0K +22.4K (+32.6%) 0.07% +0.025 pp 0.00% +0.000 pp USD3.75 -22.7% 18 qtrs
27 POINT72 ASSET MANAGEMENT, L.P. 30.4K +30.4K (+100.0%) 88.1K +88.1K (+100.0%) 0.07% +0.068 pp 0.00% +0.000 pp USD2.90 +0.0% 1 qtrs NEW
28 BARCLAYS PLC 24.9K +24.9K (+100.0%) 72.1K +72.1K (+100.0%) 0.06% +0.056 pp 0.00% +0.000 pp USD2.90 +0.0% 1 qtrs NEW
29 OMERS ADMINISTRATION CORP 24.4K +24.4K (+100.0%) 70.8K +70.8K (+100.0%) 0.05% +0.055 pp 0.00% +0.001 pp USD2.90 +0.0% 1 qtrs NEW
30 FIFTH LANE CAPITAL, LP 17.7K +17.7K (+100.0%) 51.3K +51.3K (+100.0%) 0.04% +0.040 pp 0.04% +0.039 pp USD2.90 +0.0% 1 qtrs NEW
31 AMERICAN CENTURY COMPANIES INC 16.9K +— (+0.0%) 49.1K -7.4K (-13.2%) 0.04% +0.000 pp 0.00% +0.000 pp USD2.90 +0.0% 4 qtrs
32 LIGHTHOUSE INVESTMENT PARTNERS, LLC 15.7K +15.7K (+100.0%) 45.6K +45.6K (+100.0%) 0.04% +0.035 pp 0.00% +0.001 pp USD2.90 +0.0% 1 qtrs NEW
33 LEGATO CAPITAL MANAGEMENT LLC 14.7K +— (+0.0%) 42.6K -6.5K (-13.2%) 0.03% +0.000 pp 0.00% -0.002 pp USD2.64 +9.8% 4 qtrs
34 ADVISOR GROUP HOLDINGS, INC. 14.3K +14.0K (+4,666.7%) 41.5K +40.5K (+4,088.9%) 0.03% +0.031 pp 0.00% +0.000 pp USD2.89 +0.3% 4 qtrs
35 BANK OF AMERICA CORP /DE/ 12.9K +12.9K (+86,093.3%) 37.5K +37.4K (+74,888.0%) 0.03% +0.029 pp 0.00% +0.000 pp USD2.90 +0.0% 9 qtrs
36 BNP PARIBAS ARBITRAGE, SNC 11.1K +7.5K (+206.1%) 32.2K +20.1K (+165.8%) 0.02% +0.017 pp 0.00% +0.000 pp USD3.04 -4.6% 2 qtrs
37 CITIGROUP INC 4.8K +4.8K (+483,100.0%) 14.0K +14.0K (+467,000.0%) 0.01% +0.011 pp 0.00% +0.000 pp USD2.90 +0.0% 2 qtrs
38 RESOURCES MANAGEMENT CORP /CT/ /ADV 500.00 +— (+0.0%) 1.0K -1.0K (-50.0%) 0.00% +0.000 pp 0.00% 0.000 pp USD2.64 +9.8% 4 qtrs
39 TOWER RESEARCH CAPITAL LLC (TRC) 317.00 +317.0 (+100.0%) 919.00 +919.0 (+100.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD2.90 +0.0% 1 qtrs NEW
40 JPMORGAN CHASE & CO 109.00 +— (+0.0%) 316.00 -48.0 (-13.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.31 +121.4% 18 qtrs
41 UBS GROUP AG 41.00 -249.0 (-85.9%) 119.00 -850.0 (-87.7%) 0.00% -0.001 pp 0.00% +0.000 pp USD3.44 -15.7% 4 qtrs
42 SBI SECURITIES CO., LTD. 15.00 -2.0 (-11.8%) 44.00 -13.0 (-22.8%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.60 +11.5% 4 qtrs
43 HUDSON BAY CAPITAL MANAGEMENT LP -11.5K (-100.0%) -38.3K (-100.0%) 0.00% -0.026 pp 0.00% 0.000 pp USD 2 qtrs SOLD
44 XTX TOPCO LTD -22.2K (-100.0%) -74.0K (-100.0%) 0.00% -0.050 pp 0.00% -0.004 pp USD 6 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 15 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 iShares Micro-Cap ETF IWC 0.02% 229.9K 0.60%
2 Avantis U.S. Small Cap Equity ETF AVSC 0.00% 23.9K 0.25%
3 U.S. Micro Cap Portfolio ETF DFMC 0.00% 45.6K 0.43%
4 Vanguard Extended Market ETF VXF 0.00% 398.3K 0.05%
5 Dimensional - US Small Cap ETF DFAS 0.00% 53.5K 0.26%
6 Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO 0.00% 648.78 0.17%
7 Vanguard U.S. Total Market Shares Index ETF VTS.AX 0.00% 3.2K 0.03%
8 Vanguard U.S. Total Market Index ETF VUN.TO 0.00% 8.8K 0.17%
9 Vanguard Total Stock Market ETF VTI 0.00% 1.50M 0.03%
10 Vanguard All-Equity ETF Portfolio VEQT.TO 0.00% 3.3K 0.22%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
3.00
Bullish
Buys
8
Sells
16
Shares acquired
1.93M
Shares disposed
407.1K
Cash buys
Cash sales
14.00
Net activity
+1,525,795
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-11 Wilson John J. Addington Officer S-Sale D Class A Common Stock 9,603 4.32 41.5K 316,762 D
2026-03-11 WIRTJES SEAN M Officer S-Sale D Class A Common Stock 7,480 4.32 32.3K 556,194 D
2026-03-10 Spignesi Robert G. Jr. Director / Officer S-Sale D Class A Common Stock 17,922 4.11 73.7K 1,169,848 D
2026-02-27 RICCIARDI NATALE S Director M-Exempt A Class A Common Stock 842 0.75 631.50 29,442 D
2026-02-20 Wilson John J. Addington Officer S-Sale D Class A Common Stock 5,403 3.92 21.2K 326,365 D
2026-02-20 WIRTJES SEAN M Officer S-Sale D Class A Common Stock 17,254 3.92 67.7K 563,674 D
2026-02-19 Spignesi Robert G. Jr. Director / Officer S-Sale D Class A Common Stock 38,327 3.89 148.9K 1,187,770 D
2026-02-11 Wilson John J. Addington Officer A-Award A Class A Common Stock 74,000 0.00 331,768 D
2026-02-11 WIRTJES SEAN M Officer A-Award A Stock Option (Right to Buy) 193,000 4.20 810.6K 193,000 D
2026-02-11 Spignesi Robert G. Jr. Director / Officer A-Award A Stock Option (Right to Buy) 528,000 4.20 2.22M 528,000 D
2026-02-09 Wilson John J. Addington Officer S-Sale D Class A Common Stock 4,610 3.78 17.4K 257,768 D
2026-02-09 WIRTJES SEAN M Officer S-Sale D Class A Common Stock 6,027 3.78 22.8K 483,928 D
2026-02-09 Spignesi Robert G. Jr. Director / Officer S-Sale D Class A Common Stock 12,840 3.78 48.6K 962,097 D
2026-02-04 Longitude Capital Partners II, LLC 10% Owner S-Sale D Class A Common Stock 49,000 3.88 190.1K 0 I
2026-02-03 Longitude Capital Partners II, LLC 10% Owner S-Sale D Class A Common Stock 27,500 4.24 116.6K 49,000 I
2026-02-02 Longitude Capital Partners II, LLC 10% Owner S-Sale D Class A Common Stock 27,500 4.25 116.8K 76,500 I
2026-01-30 Longitude Capital Partners II, LLC 10% Owner S-Sale D Class A Common Stock 46,000 4.54 209.0K 104,000 I
2026-01-23 Longitude Capital Partners II, LLC 10% Owner X-InTheMoney A Class A Common Stock 629,032 0.05 31.5K 4,036,984 I
2025-11-14 Malloy Kirk Director G-Gift D Class A Common Stock 40,000 0.00 28,600 D
2025-10-17 Spignesi Robert G. Jr. Director / Officer M-Exempt A Class A Common Stock 7,833 0.75 5.9K 979,711 D
2025-07-14 Spignesi Robert G. Jr. Director / Officer M-Exempt A Class A Common Stock 25,145 0.00 982,431 D
2025-07-11 Spignesi Robert G. Jr. Director / Officer M-Exempt A Class A Common Stock 25,145 0.00 969,160 D
2025-07-10 Spignesi Robert G. Jr. Director / Officer S-Sale D Class A Common Stock 11,617 3.40 39.5K 944,015 D
2025-07-09 Spignesi Robert G. Jr. Director / Officer M-Exempt A Class A Common Stock 25,144 0.00 911,830 D
2025-07-08 Spignesi Robert G. Jr. Director / Officer M-Exempt A Class A Common Stock 25,144 0.00 897,510 D
2025-05-22 RICCIARDI NATALE S Director A-Award A Class A Common Stock 14,300 0.00 28,600 D
2025-05-22 PEI MELINDA LITHERLAND Director A-Award A Stock Option (Right to Buy) 28,650 3.15 90.2K 28,650 D
2025-05-22 Malloy Kirk Director A-Award A Stock Option (Right to Buy) 28,650 3.15 90.2K 28,650 D
2025-05-22 LOWENSTEIN INESE Director A-Award A Stock Option (Right to Buy) 28,650 3.15 90.2K 28,650 D
2025-05-22 Kollender Richard S Director A-Award A Class A Common Stock 14,300 0.00 111,018 D
2025-05-22 Bika Dafni Director A-Award A Stock Option (Right to Buy) 50,000 3.15 157.5K 50,000 D
2025-03-09 Wilson John J. Addington Officer F-InKind D Class A Common Stock 9,872 2.39 23.6K 232,474 D
2025-03-09 WIRTJES SEAN M Officer F-InKind D Class A Common Stock 7,690 2.39 18.4K 489,955 D
2025-03-09 Spignesi Robert G. Jr. Director / Officer F-InKind D Class A Common Stock 10,650 2.39 25.5K 872,366 D
2025-02-18 Wilson John J. Addington Officer A-Award A Class A Common Stock 44,000 0.00 242,346 D
2025-02-18 WIRTJES SEAN M Officer A-Award A Class A Common Stock 160,000 0.00 497,645 D
2025-02-18 Spignesi Robert G. Jr. Director / Officer A-Award A Class A Common Stock 365,000 0.00 883,016 D
2025-02-11 Wilson John J. Addington Officer F-InKind D Class A Common Stock 7,075 2.68 19.0K 198,346 D
2025-02-11 WIRTJES SEAN M Officer F-InKind D Class A Common Stock 4,621 2.68 12.4K 337,645 D
2025-02-11 Spignesi Robert G. Jr. Director / Officer F-InKind D Class A Common Stock 10,755 2.68 28.8K 516,205 D
2025-02-06 Wilson John J. Addington Officer F-InKind D Class A Common Stock 4,505 3.10 14.0K 205,421 D
2025-02-06 WIRTJES SEAN M Officer F-InKind D Class A Common Stock 5,891 3.10 18.3K 342,266 D
2025-02-06 Spignesi Robert G. Jr. Director / Officer F-InKind D Class A Common Stock 13,052 3.10 40.5K 526,960 D
2024-12-05 PEI MELINDA LITHERLAND Director P-Purchase A Class A Common Stock 9,120 1.04 9.5K 54,300 D
2024-12-03 PEI MELINDA LITHERLAND Director P-Purchase A Class A Common Stock 10,880 1.00 10.9K 45,180 D
2024-11-27 PEI MELINDA LITHERLAND Director P-Purchase A Class A Common Stock 19,892 1.05 20.9K 34,300 D
2024-11-26 PEI MELINDA LITHERLAND Director P-Purchase A Class A Common Stock 108 1.04 112.32 14,408 D
2024-08-08 Malloy Kirk Director P-Purchase A Class A Common Stock 50,000 0.91 45.3K 64,300
2024-08-07 WIRTJES SEAN M Officer P-Purchase A Class A Common Stock 10,000 0.78 7.8K 348,157
2024-08-06 Spignesi Robert G. Jr. Director / Officer P-Purchase A Class A Common Stock 50,000 0.77 38.4K 540,012
2024-08-06 Kollender Richard S Director P-Purchase A Class A Common Stock 65,000 0.77 50.1K 96,718
2024-05-23 Schwartz Jeffrey Lawrence Director / 10% Owner A-Award A Class A Common Stock 14,300 0.00 14,300
2024-05-23 RICCIARDI NATALE S Director A-Award A Class A Common Stock 14,300 0.00 14,300
2024-05-23 PEI MELINDA LITHERLAND Director A-Award A Stock Option (Right to Buy) 28,650 0.82 23.5K 28,650
2024-05-23 Malloy Kirk Director A-Award A Class A Common Stock 14,300 0.00 14,300
2024-05-23 LOWENSTEIN INESE Director A-Award A Stock Option (Right to Buy) 28,650 0.82 23.5K 28,650
2024-05-23 Kollender Richard S Director A-Award A Stock Option (Right to Buy) 28,650 0.82 23.5K 28,650
2024-05-23 Hirsch David Director A-Award A Class A Common Stock 14,300 0.00 14,300
2024-03-11 Wilson John J. Addington Officer F-InKind D Class A Common Stock 9,569 0.98 9.4K 188,738
2024-03-11 WIRTJES SEAN M Officer F-InKind D Class A Common Stock 7,454 0.98 7.3K 325,403
2024-03-11 VEZINA VICTORIA Officer F-InKind D Class A Common Stock 5,435 0.98 5.3K 112,608
2024-03-11 Spignesi Robert G. Jr. Director / Officer F-InKind D Class A Common Stock 10,323 0.98 10.1K 468,824
2024-02-12 Wilson John J. Addington Officer F-InKind D Class A Common Stock 5,809 0.96 5.6K 198,307
2024-02-12 WIRTJES SEAN M Officer F-InKind D Class A Common Stock 3,794 0.96 3.6K 332,857
2024-02-12 VEZINA VICTORIA Officer F-InKind D Class A Common Stock 2,727 0.96 2.6K 118,043
2024-02-12 Spignesi Robert G. Jr. Director / Officer F-InKind D Class A Common Stock 9,365 0.96 9.0K 479,147
2024-02-06 Wilson John J. Addington Officer A-Award A Class A Common Stock 39,000 0.00 204,116
2024-02-06 WIRTJES SEAN M Officer A-Award A Class A Common Stock 51,000 0.00 336,651
2024-02-06 VEZINA VICTORIA Officer A-Award A Class A Common Stock 28,000 0.00 120,770
2024-02-06 Spignesi Robert G. Jr. Director / Officer A-Award A Class A Common Stock 113,000 0.00 488,512
2023-09-06 WIRTJES SEAN M Officer P-Purchase A Class A Common Stock 10,000 0.99 9.9K 285,651
2023-08-15 Spignesi Robert G. Jr. Director / Officer P-Purchase A Class A Common Stock 20,000 0.97 19.5K 375,512
2023-08-08 Spignesi Robert G. Jr. Director / Officer P-Purchase A Class A Common Stock 34,000 0.92 31.4K 355,512
2023-07-14 Malloy Kirk Director 0 0.00 0
2023-05-17 Spignesi Robert G. Jr. Director / Officer P-Purchase A Class A Common Stock 100 0.90 90.10 295,073
2023-05-04 Schwartz Jeffrey Lawrence Director / 10% Owner A-Award A Stock Option (Right to Buy) 25,000 0.87 21.8K 25,000
2023-05-04 RICCIARDI NATALE S Director A-Award A Stock Option (Right to Buy) 25,000 0.87 21.8K 25,000
2023-05-04 PEI MELINDA LITHERLAND Director A-Award A Stock Option (Right to Buy) 25,000 0.87 21.8K 25,000
2023-05-04 LOWENSTEIN INESE Director A-Award A Stock Option (Right to Buy) 25,000 0.87 21.8K 25,000
2023-05-04 Kollender Richard S Director A-Award A Stock Option (Right to Buy) 25,000 0.87 21.8K 25,000
2023-05-04 Hirsch David Director A-Award A Stock Option (Right to Buy) 25,000 0.87 21.8K 25,000
2023-03-09 Wilson John J. Addington Officer A-Award A Class A Common Stock 100,900 0.00 158,377
2023-03-09 WIRTJES SEAN M Officer A-Award A Stock Option (Right to Buy) 198,600 1.24 246.3K 198,600
2023-03-09 VEZINA VICTORIA Officer A-Award A Class A Common Stock 57,300 0.00 86,031
2023-03-09 Spignesi Robert G. Jr. Director / Officer A-Award A Stock Option (Right to Buy) 217,700 1.24 269.9K 217,700
2023-03-09 Paris Jonathan Officer A-Award A Stock Option (Right to Buy) 196,700 1.24 243.9K 196,700
2023-02-13 Wilson John J. Addington Officer F-InKind D Class A Common Stock 7,075 1.30 9.2K 57,477
2023-02-13 WIRTJES SEAN M Officer F-InKind D Class A Common Stock 4,621 1.30 6.0K 190,312
2023-02-13 VEZINA VICTORIA Officer F-InKind D Class A Common Stock 3,321 1.30 4.3K 28,731
2023-02-13 Spignesi Robert G. Jr. Director / Officer F-InKind D Class A Common Stock 11,406 1.30 14.8K 185,923
2023-02-13 Paris Jonathan Officer F-InKind D Class A Common Stock 5,054 1.30 6.6K 41,998
2022-06-03 KENNEDY LEWIS MANAGEMENT LP 10% Owner P-Purchase A Common Stock 29,398 4.66 137.1K 2,904,490
2022-06-02 KENNEDY LEWIS MANAGEMENT LP 10% Owner P-Purchase A Common Stock 5,938 4.99 29.6K 2,875,092
2022-06-02 CHENE DAVID Director P-Purchase A Common Stock 20,602 4.66 96.1K 2,035,441
2022-06-01 KENNEDY LEWIS MANAGEMENT LP 10% Owner P-Purchase A Common Stock 27,703 4.76 131.9K 2,869,154
2022-05-31 KENNEDY LEWIS MANAGEMENT LP 10% Owner P-Purchase A Common Stock 11,759 5.11 60.1K 2,841,451
2022-05-27 KENNEDY LEWIS MANAGEMENT LP 10% Owner P-Purchase A Common Stock 882 5.26 4.6K 2,829,692
2022-05-27 CHENE DAVID Director P-Purchase A Common Stock 19,414 4.76 92.4K 2,010,677
2022-05-26 KENNEDY LEWIS MANAGEMENT LP 10% Owner P-Purchase A Common Stock 12,396 4.90 60.8K 2,828,810
2022-05-25 KENNEDY LEWIS MANAGEMENT LP 10% Owner P-Purchase A Common Stock 11,867 4.36 51.7K 1,973,717
2022-05-25 CHENE DAVID Director P-Purchase A Common Stock 12,396 4.90 60.8K 2,828,810
2022-05-23 Schwartz Jeffrey Lawrence Director A-Award A Stock Option (right to buy) 12,500 0.00 12,500
2022-05-23 RICCIARDI NATALE S Director A-Award A Stock Option (Right to Buy) 12,500 0.00 12,500
2022-05-23 PEI MELINDA LITHERLAND Director A-Award A Stock Option (Right to Buy) 12,500 0.00 12,500
2022-05-23 Kollender Richard S Director A-Award A Stock Option (Right to Buy) 12,500 4.50 56.3K 12,500
2022-05-23 Hirsch David Director / 10% Owner A-Award A Stock Option (Right to Buy) 12,500 4.50 56.3K 12,500
2022-05-18 KENNEDY LEWIS MANAGEMENT LP 10% Owner P-Purchase A Common Stock 11,125 3.94 43.9K 1,961,850
2022-05-17 KENNEDY LEWIS MANAGEMENT LP 10% Owner I Common Stock 0 0.00 1,922,082
2022-05-17 CHENE DAVID Director P-Purchase A Common Stock 11,125 3.94 43.9K 1,961,850
2022-05-16 Spignesi Robert G. Jr. Officer P-Purchase A Class A Common Stock 10,000 3.80 38.0K 194,027
2022-03-17 WIRTJES SEAN M Officer M-Exempt D Stock Option (Right to Buy) 10,000 0.00 82,886
2022-03-14 Spignesi Robert G. Jr. Officer M-Exempt A Class A Common Stock 35,000 1.00 35.0K 184,027
2022-03-10 LOWENSTEIN INESE Director P-Purchase A Class A Common Stock 10,000 6.95 69.5K 10,000
2022-02-11 Wilson John J. Addington Officer A-Award A Class A Common Stock 61,250 0.00 61,250
2022-02-11 WIRTJES SEAN M Officer A-Award A Stock Option (Right to Buy) 80,000 7.82 625.6K 80,000
2022-02-11 VEZINA VICTORIA Officer A-Award A Class A Common Stock 28,750 0.00 28,750
2022-02-11 Spignesi Robert G. Jr. Director / Officer A-Award A Class A Common Stock 98,750 0.00 149,027
2022-02-11 Paris Jonathan Officer A-Award A Stock Option (Right to Buy) 87,500 7.82 684.3K 87,500
2022-02-11 KEYS RICHARD A Officer A-Award A Class A Common Stock 43,750 0.00 43,750
2021-12-17 LOWENSTEIN INESE Director A-Award A Stock Option (Right to Buy) 25,000 11.23 280.8K 25,000
2021-10-01 KEYS RICHARD A Officer 0 0.00 0
2021-09-09 Kollender Richard S Director X-InTheMoney D Series A1 Warrant (right to buy) 82,010 0.05 4.1K 0
2021-07-19 Longitude Prime Partners, LLC 10% Owner I Class A Common Stock 0 0.00 150,000
2021-07-19 Longitude Capital Partners II, LLC 10% Owner C-Conversion A Common Stock Warrant 500,000 0.05 25.0K 500,000
2021-07-19 Kollender Richard S Director C-Conversion A Common Stock Warrant 12,903 0.05 645.15 12,903
2021-07-19 Hirsch David Director / 10% Owner C-Conversion D Series C1 Preferred Stock 2,291,665 0.00 0
2021-07-19 Grewal Gurinder 10% Owner C-Conversion D Series D1 Preferred Stock 138,888 0.00 0
2021-07-19 Bain Capital Life Sciences Investors, LLC 10% Owner P-Purchase A Class A Common Stock 100,000 20.00 2.00M 8,434,560
2021-07-14 Wilson John J. Addington Officer D Stock Option (Right to Buy) 248,903 2.10 522.7K 0
2021-07-14 WIRTJES SEAN M Officer D Class A Common Stock 0 0.00 141,631
2021-07-14 VEZINA VICTORIA Officer D Stock Option (Right to Buy) 12,157 10.85 131.9K 0
2021-07-14 Spignesi Robert G. Jr. Director / Officer D Common Warrant 6 298.96 1.8K 0
2021-07-14 Schwartz Jeffrey Lawrence Director / 10% Owner A-Award A Stock Option (Right to Buy) 25,000 20.00 500.0K 25,000
2021-07-14 Schmitz Alexander Director 0 0.00 0
2021-07-14 RICCIARDI NATALE S Director D Stock Option (Right to Buy) 842 0.75 631.50 0
2021-07-14 Paris Jonathan Officer D Stock Option (Right to Buy) 120,000 11.45 1.37M 0
2021-07-14 PEI MELINDA LITHERLAND Director 0 0.00 0
2021-07-14 Noyes Michael Andrew 10% Owner D Stock Option (Right to Buy) 16,764 0.75 12.6K 0
2021-07-14 Longitude Capital Partners II, LLC 10% Owner I Class A Common Stock 0 0.00 63,914
2021-07-14 LOWENSTEIN INESE Director A-Award A Stock Option (Right to Buy) 25,000 11.23 280.8K 25,000
2021-07-14 Kollender Richard S Director I Class A Common Stock 0 0.00 58,109
2021-07-14 Hirsch David Director / 10% Owner I Class A Common Stock 0 0.00 63,914
2021-07-14 Grewal Gurinder 10% Owner D Class A Common Stock 0 0.00 267,213
2021-07-14 Bain Capital Life Sciences Investors, LLC 10% Owner I Series B1 Preferred Stock 6,999,998 0.00 0
2020-05-14 KENNEDY LEWIS MANAGEMENT LP 10% Owner I Warrants 239,130 5.75 1.37M 0

Executive team

Top executives
EBIT / Employee
-290.7K
Shares Outstanding
45.77M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Robert Spignesi Chief Executive Officer 663.6K 1.42M 609.0K 490.5K 38.9K 3.23M 63.01%
2 2025 Sean Wirtjes Chief Financial Officer 465.7K 624.0K 254.1K 215.5K 30.0K 1.59M 55.25%
3 2025 John Wilson Chief Operating Officer 465.7K 171.6K 186.9K 207.4K 31.1K 1.06M 33.73%
4 2024 Robert Spignesi Chief Executive Officer 641.2K 100.5K 106.4K 110.3K 312.9K 42.4K 1.31M 16.50%
5 2024 Sean Wirtjes Chief Financial Officer 449.9K 33.1K 48.0K 50.5K 150.5K 30.9K 762.9K 12.91%
6 2024 John Wilson Chief Operating Officer 449.9K 33.1K 36.7K 38.7K 136.8K 30.6K 725.8K 10.40%
7 2023 Robert Spignesi Chief Executive Officer 616.5K 607.4K 137.2K 401.2K 35.0K 1.80M 41.43%
8 2023 John Wilson Chief Operating Officer 432.6K 62.4K 125.1K 132.9K 175.2K 29.7K 957.9K 26.93%
9 2023 Sean Wirtjes Chief Financial Officer 432.6K 62.4K 97.5K 125.1K 177.1K 29.1K 923.8K 24.09%
10 2022 Robert Spignesi Chief Executive Officer 592.8K 96.1K 772.2K 674.2K 46.2K 42.5K 2.22M 65.04%
11 2022 John Wilson Chief Operating Officer 416.0K 10.4K 479.0K 418.2K 52.0K 34.5K 1.41M 63.62%
12 2022 Sean Wirtjes Chief Financial Officer 416.0K 12.5K 312.8K 273.1K 49.9K 32.2K 1.10M 53.43%
13 2021 Richard Keys Chief Commercial Officer 102.1K 75.0K 1.41M 40.7K 10.1K 1.64M 86.09%
14 2021 Robert Spignesi Chief Executive Officer 507.3K 575.9K 342.0K 34.4K 1.46M 39.46%
15 2021 John Wilson Chief Operating Officer 374.9K 173.2K 311.6K 149.6K 211.3K 1.22M 25.53%
16 2021 Sean Wirtjes Chief Financial Officer 372.5K 115.4K 150.0K 32.2K 670.1K 17.22%
17 2020 Robert Spignesi Chief Executive Officer 445.2K 301.8K 311.6K 32.2K 1.09M 27.66%
18 2020 Sean Wirtjes Chief Financial Officer 342.5K 59.5K 180.3K 31.6K 613.8K 9.69%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-08 DEFA14A
2026-04-08 DEF 14A
2025-04-08 DEFA14A
2025-04-08 DEF 14A
2024-04-09 DEFA14A
2024-04-09 DEF 14A
2024-03-27 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-04-08 DEFA14A
2026-04-08 DEF 14A
2026-04-08 ARS
2026-03-27 8-K
2026-03-12 S-8
2026-03-12 8-K
2026-03-12 4
2026-03-12 4
2026-03-12 4
2026-03-12 10-K

Executive team

NameTitleCompensationGender
Robert G. Spignesi Jr. CEO, President, COO & Director 1M male
Sean Wirtjes Chief Financial Officer 711.2K male
John J. Addington Wilson Chief Operating Officer 650.3K male
Michael Beaulieu Vice President of Investor Relations & Corporate Communications male
Katherine Atkinson Senior VP of Global Sales & Marketing female
Julie Jarvie Senior Vice President of Human Resources female
James Xu Senior Vice President of Legal & Secretary male
ESG Rating
B
MEDICAL - DEVICES
Rank: 19 out of 152
2025
E (Environmental)
50.0 / 62.5
Company / Sector avg.
S (Social)
83.8 / 68.9
Company / Sector avg.
G (Governance)
69.3 / 64.8
Company / Sector avg.
ESG Total
67.7 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits